000858.SZ · A-shares

000858.SZ Wuliangye: sell-through restatement and governance discount

Wuliangye restated 2025 revenue ¥40.529B (−54.6%), parent NI ¥8.954B (−71.9%); cash ~¥127B. 2026Q1 parent NI ¥8.063B; H1 guide ¥8.73–9.20B. 8/17 close ¥72.55 / mkt ~¥282B. See Moutai.

Published Updated Open interactive reader

Download MarkdownExport PDF

Cite a section with a deep link, e.g. /en/r/wuliangye-000858-research#thesis

Market snapshot

A-share (8/17)
CNY 72.55
Market cap (approx)
CNY 281.6B
2025 parent NI (restated)
CNY 9.0B
H1'26 NI guide midpoint
CNY 9.0B
As of 2026-09-25

As-of 2026-09-25 (weekly refresh; equities aligned to §A. Missing series are N/A/null. Not investment advice.)

Thesis

Wuliangye (000858.SZ) is the No. 2 premium strong-aroma baijiu name, anchored on 8th-gen Wuliangye. After switching revenue recognition to terminal sell-through, 2025 revenue ¥40.529B (−54.55%) and parent NI ¥8.954B (−71.89%) — optical collapse, while OCF was still ¥29.706B and cash ~¥127.0B. 2026Q1 revenue ¥22.838B (+33.7%), parent NI ¥8.063B (+82.6%); H1 NI guide ¥8.73–9.20B (+89%–+99%), mostly a restated low base plus peak-season sell-through, with Q2 sequential profit dropping hard.

Close 2026-08-17: ¥72.55, mkt ~¥282B. The tape prices governance discount (chair detention) + true sell-through after the accounting reset. Anchor peer: Moutai. Formal H1'26 revenue was not out at cutoff — use the profit pre-announcement and Q1.

Business

Model: strong-aroma fermentation → aged base liquor → Wuliangye and series via dealers/direct. Profit is premium brand rent; cash-before-delivery.

Flagships:

  1. 8th-gen Wuliangye (WLY products) — 2025 ¥27.936B (−58.8% restated), GM 89.55%; ~¥1,000 price band, volume-price balance.
  2. Series (Wuliangchun / Wuliangchun / Jianzhuang etc.) — ¥9.168B (−39.9%), GM 66.10%.
  3. Younger / occasion SKUs — e.g. World Cup collab (news: >¥1.6B H1'26 sales) as new-user tests, not the P&L core.

Edge: (1) No. 2 premium strong-aroma mindshare; (2) specialty stores + 2,562 brand dealers, cash-before-delivery.

Strategy: execution year, tighter quotas, inventory toward ~1–1.5 months; recognition now tracks sell-through — uglier prints, more verifiable. Q1'26 openings/inlet counts improved (sell-side); Q2 profit warns against annualizing CNY.

Strategy pillars

Strategy pillars
PillarDetail
主业定位高端浓香第二极;「一核两擎两驱一新」,第八代五粮液为核心大单品
产量 / 库存2025 酒类销量 11.30 万吨(−30.3%);成品酒库存 +45.2%——主动去渠道、报表向动销靠拢
量价平衡第八代坚持千元价格带;批价与配额精细化,渠道库存目标压至 1–1.5 个月
收入确认2025 年报改为终端动销完成才确认收入;表观腰斩,后续报表更贴近开瓶/动销
股东回报2025 拟分红 100.07 亿 + 回购 80–100 亿;叠加中期分红兑现三年回报规划
As of 2026-09-25

Entity boundary: Wuliangye Yibin Co., Ltd. (000858.SZ); parent is the Group. 2025–26: no liquidation/resumption, but material governance events and accounting restatement.

Value chain

Position: midstream branded distiller — premium strong-aroma rent.

Side Counterparties Dependence
Upstream Grain, packaging, pits, 100kt eco-brew projects Top-5 suppliers 29.6% of purchases; related 13.4%
Downstream Dealers, stores, Tmall/JD/WeChat, group-buy Banquet/gifting; batch price forms in wholesale

Customer structure

Customer structure
ItemValueNote
客户类型经销商为主 + 专卖店/电商/团购直销先款后货
前五大客户14.55%(58.97 亿)2025 年报;关联方占销售 2.06%
经销商五粮液品牌 2562 家;浓香系列 1171 家;合计 3733五粮液品牌经销商净减 90 家
直销 vs 经销直销 145.12 亿(毛利率 90.4%);经销 225.92 亿(79.5%)重述后直销占比仍高
片区南部 178.25 亿 / 东部 128.32 亿 / 北部 64.47 亿均为酒类口径,同比腰斩主因确认时点
As of 2026-09-25

Concentration: 2025 top-5 14.55% (¥5.897B); related 2.06% of sales. Largest customer unnamed.

Supply risks: (1) related-supplier concentration; (2) finished-goods inventory +45% in 2025 as channel stock moved onto the factory — echoed in risks.

Corporate events

The restatement and chair detention dominate 36m — keep them separate from run-rate operations.

Corporate events

Corporate events
DatePhaseEventMeaning
2025-06人事董事会换届:华涛任总经理、章欣任财务总监兼董秘经营层换届,曾从钦仍任董事长
2026-02-28治理董事长曾从钦留置;股份公司公告立案/留置通知书治理折价;前任李曙光 2025-01 亦被查
2026-04-30会计年报 + 前期差错更正:2025 营收 405.29 亿(−54.6%)、归母 89.54 亿(−71.9%)收入确认改为终端动销;前三季度累计营收下调约 303 亿
2026-04-30回购推出 80–100 亿回购计划用现金回购对冲信任折价
2026-04-30财报2026Q1 营收 228.38 亿(+33.7%)、归母 80.63 亿(+82.6%)低基数 + 旺季动销;单季利润接近 2025 全年
2026-06-26人事股东会免去曾从钦董事;选举邓敏为董事长真空期结束,新董事长来自宜宾国资系统
2026-07-15预告2026H1 归母预告 87.3–92.0 亿(+88.8%–+99.0%)Q2 环比大幅回落;正式中报截止日前未披露营收
As of 2026-09-25

Valuation

¥72.55 / ~¥282B (2026-08-17). Do not read 31x on restated ¥8.954B NI — the denominator was crushed by policy. Cleaner: forward earnings (street ~¥16B → ~16–18x) + net cash + buyback/dividend.

Valuation snapshot (multi-lens)

Valuation snapshot (multi-lens)
MetricValueNote
现价 / 市值72.55 元 / 约 2816 亿2026-08-17;股本约 38.82 亿
静态 P/E(2025 重述)约 31x口径被洗大澡扭曲,不宜直接横比历史
前瞻 P/E(示意)约 16–18x若 2026 归母落在约 160 亿分析师区间
P/B约 2.4x账面现金约 1270 亿提供底仓
盈利收益率重述静态约 3.2%;前瞻约 5.5%–6%1/PE
股息率年报拟派约 3.6%;含中期或更高拟派 100.07 亿;回购额额外 80–100 亿
As of 2026-09-25

~3y tape (P/E jumps in 2026Q1 on the restated denominator — an optics effect):

Valuation & returns · ~3y

Interactive chart available in the reader.

Illustrative public-market quarter-ends; yield and trailing return approximate — terminals prevail · As of 2026-09-25

Share price · ~3y

Interactive chart available in the reader.

Quarterly close reconstruction (illustrative, split-adjusted approx.) · As of 2026-09-25

Financial trend (~24 months)

Eight quarters: 2024 quarters reconstructed from FY original; 2025 quarters are restated official; 2026Q1 is the formal print. 2025 YoY collapse is timing of recognition, not vanished stills. Q1 is the seasonal peak.

Revenue · last 8 quarters

Interactive chart available in the reader.

2024 quarters reconstructed from original FY; 2025 quarters are restated official; 2026Q1 is the formal print. YoY collapse is recognition timing. · As of 2026-09-25

Gross margin · last 8 quarters

Interactive chart available in the reader.

Blended GM from FY/H1 anchors; quarterly interpolated (ppt changes) · As of 2026-09-25

Liquor GM 83.75% in 2025 (+1.54ppt); quarterly GM is interpolated around that level.

Financial health

Cash fortress, P&L optics broken. OCF ¥29.7B ≫ restated NI — not a cash collapse.

Financial health (OCF / debt / liquidity / audit)

Financial health (OCF / debt / liquidity / audit)
ItemValueNote
财务健康总评现金充裕,报表口径剧变资产负债表仍强;利润表 2025 不可直接外推
经营现金流 2025297.06 亿(−12.5%)OCF 远高于重述净利,反映确认时点后移而非现金枯竭
货币资金1270.14 亿(2025 末)约占总资产 67%
有息债 vs 现金净现金白酒龙头典型预收款+存款结构
流动性先款后货;关注预收款与库存
审计 / 持续经营天职国际;年报无持续经营强调同期发布前期差错更正,信息披露争议是治理风险而非偿债风险
As of 2026-09-25

Net income · last 8Q

Interactive chart available in the reader.

Reconstructed from public filings (illustrative; attributable NI) · As of 2026-09-25

Operations

2025 liquor volume 113.0kt (−30.3%), inventory 47.6kt (+45.2%) — de-stocking from channel onto books. 2026 start: 8th-gen sell-through double-digit, inventory 1–1.5 months (sell-side/news). H1 revenue awaits the interim.

Segments / mix

Segments / mix
SegmentScale / mixWatchpoint
五粮液产品2025 年 279.36 亿(−58.8%),毛利率 89.55%第八代为核心;口径重述是主因
其他酒91.68 亿(−39.9%),毛利率 66.10%五粮春/五粮醇/尖庄等
2026Q1营收 228.38 亿(+33.7%);归母 80.63 亿(+82.6%)对重述后低基数;旺季动销回暖
2026H1 预告归母 87.3–92.0 亿(+89%–+99%)营收待正式中报;Q2 利润环比显著回落
As of 2026-09-25

Competition

Peers: Moutai, Luzhou Laojiao 000568, Yanghe 002304.

Strengths: No. 2 premium mindshare; net cash and buybacks; store network. Weaknesses: governance discount; history not comparable post-restatement; more demand-elastic than Flying Fairy.

Punchline: rank intact; 2026 is trust repair + sell-through proof, not a share-gain year.

Market share trend · last 8Q

Interactive chart available in the reader.

Industry reports + public disclosures (illustrative estimate) · As of 2026-09-25

Peer market share comparison (latest est.)

Interactive chart available in the reader.

Industry reports + public disclosures (illustrative estimate) · As of 2026-09-25

Peer comparison

Peer comparison
CompanyPosition / shareGross marginStrengthWeakness
五粮液 000858高端浓香第二极酒类 83.8%(2025 重述)第八代品牌与渠道;净现金治理事件 + 会计重述信任折价
贵州茅台 600519超高端酱香锚91%+品牌与配额壁垒批价/直营改革期增速放缓
泸州老窖 000568高端浓香直接竞品高国窖 1573需求下行弹性大
洋河股份 002304苏酒 / 次高端+低于茅五省内深度分销全国化与价格带压力
As of 2026-09-25

Management

Key management (24m)

Key management (24m)
RoleNameSince24m change
董事长邓敏2026-06接替被留置的曾从钦;2026-02 至 06 董事长真空
总经理 / 副董事长华涛2025-06换届出任总经理;年报期间曾代行法定代表人
财务总监 / 董秘章欣2025-06换届新任;主持会计工作(年报签字)
As of 2026-09-25

24m: Jun 2025 Hua Tao GM, Zhang Xin CFO; 2026-02-28 Zeng Congqin detained; 2026-06-26 Deng Min chair. Prior chair Li Shuguang was also investigated in Jan 2025. High transition risk — operations continue, dealer/SASAC confidence must be re-earned.

Outlook

Near-term: official interim revenue, advances, inventory, 8th-gen batch. Medium-term: whether FY26 profit can approach ~¥16B street once the accounting is stable — do not annualize Q1. Baijiu demand still below 2021–23.

Scenarios

Scenario Conditions Implication
Bull Sell-through holds, batch stable, governance quiet Earnings repair, 18–20x forward
Base Peak seasons work, off-peak soft, buybacks floor ¥65–90 range
Bear Another disclosure/governance shock or restocking Cash narrative breaks, wider discount

Risks

Risks (with severity)

Risks (with severity)
RiskLevelNote
治理 / 董事长留置余波高连续两任集团董事长被查;新班子执行与经销商信心
会计口径与信息披露信任高2025 前三季大幅更正;后续同比需始终标注口径
高端需求与批价中高商务宴请弱、库存若再积压将压制第八代
Q2 环比断崖是否持续中H1 预告隐含 Q2 利润远低于 Q1 旺季
上游原粮 / 包材 / 基酒中前五大供应商占采购 29.6%,关联采购 13.4%
产能项目节奏低10 万吨生态酿酒二期等;需求不足时产能是沉没成本
As of 2026-09-25

Tracking

  1. 8th-gen batch price and months of channel inventory
  2. Official H1'26 revenue, advances, inventory vs guided NI
  3. Whether post-Q2 profit keeps collapsing sequentially
  4. Buyback execution (¥8–10B)
  5. Dealer-policy shocks under the new chair

Confirm: sell-through matches cash, no more restatement ping-pong. Falsify: another large correction or forced loading.

References

  1. Wuliangye 2025 annual report — https://disc.static.szse.cn/disc/disk03/finalpage/2026-04-30/7b179575-3e07-4607-8d7e-d1bb9c4c8786.PDF
  2. H1'26 earnings pre-announcement — https://money.finance.sina.com.cn/corp/view/vCB_AllBulletinDetail.php?id=12446580&stockid=000858
  3. SZSE — https://www.szse.cn/
  4. CNINFO / SZSE search 000858
  5. Moutai standard pack

Not investment advice. 2025 quarters are not spliceable onto older quarterlies; valuation series are illustrative.

Disclaimer: For research information only. Not investment advice or a recommendation to buy or sell.

Comments

Sign in to comment

Loading…